Abstract UNLABELLED There is a need for efficacious and safe pain treatments for OA (osteoarthritis). The nerve growth factor (NGF) antibody tanezumab is associated with high efficacy, but when combined with chronic NSAID treatment shows an increased risk of rapidly progressive osteoarthritis (RPOA) in a small group of patients. AIM The aim of this study […]
Serological biomarker profiles of rapidly progressive osteoarthritis in tanezumab-treated patients.
March 1, 2019
Osteoarthritis Cartilage